Protagonist Therapeutics (NASDAQ:PTGX) Given New $53.00 Price Target at JPMorgan Chase & Co.
Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its price target lifted by analysts at JPMorgan Chase & Co. from $51.00 to $53.00 in a research note issued to investors on ...
cambridgeindependent2 天
The Core community hub opens at Orchard Park in Cambridge
A new community hub at Orchard Park in Cambridge has opened and charities hope it will help break down barriers to help people access support. The Core community centre was opened by students at ...
来自MSN2 天
Wolfe Research Initiates Coverage of Vera Therapeutics (VERA) with Outperform Recommendation
Fintel reports that on February 4, 2025, Wolfe Research initiated coverage of Vera Therapeutics (NasdaqGM:VERA) with a ...
来自MSN3 天
Vera Therapeutics initiated with an Outperform at Wolfe Research
Wolfe Research initiated coverage of Vera Therapeutics (VERA) with an Outperform rating and $49 price target The firm is ...